Bristol-Myers Squibb Financial Ratios
NYSE: BMYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bristol-Myers Squibb ratio analysis
Bristol-Myers Squibb earned a net margin of 14.6% in FY 2025, up from -18.5% a year earlier. Gross margin was 71.1% compared with a median of 72.3% over the prior 9 years. Return on equity reached 38.2%, meaning Bristol-Myers Squibb generated 0.38 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 2.44 versus 3.04 the year before, and the current ratio was 1.26. At the end of FY 2025, BMY traded at 15.5 times earnings; across the 8 fiscal years shown, its year-end P/E ranged from 13.3 to 100.5, with a median of 21.0. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Bristol-Myers Squibb financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 15.45 | — | 13.29 | 24.39 | 19.98 | — | 31.23 | 15.58 | 100.46 | 22.05 |
| Price / sales | 2.26 | 2.37 | 2.36 | 3.32 | 2.99 | 3.29 | 4.09 | 3.39 | 4.85 | 5.03 |
| Price / book | 5.89 | 7.02 | 3.61 | 4.93 | 3.85 | 3.70 | 2.07 | 5.46 | 8.59 | 6.04 |
| Gross margin | 71.1% | 71.1% | 76.2% | 78.0% | 78.6% | 72.3% | 69.1% | 71.3% | 70.7% | 74.5% |
| Net margin | 14.6% | -18.5% | 17.8% | 13.7% | 15.1% | -21.2% | 13.2% | 21.8% | 4.8% | 22.9% |
| Free cash flow margin | 26.7% | 28.9% | 28.1% | 25.9% | 32.8% | 31.3% | 28.2% | 27.1% | 20.3% | 9.5% |
| Return on equity (ROE) | 38.2% | -54.8% | 27.3% | 20.4% | 19.5% | -23.8% | 6.7% | 35.1% | 8.6% | 27.6% |
| Return on assets (ROA) | 7.8% | -9.7% | 8.4% | 6.5% | 6.4% | -7.6% | 2.6% | 14.1% | 3.0% | 13.2% |
| Debt / equity | 2.44 | 3.04 | 1.35 | 1.27 | 1.24 | 1.34 | 0.91 | 0.52 | 0.68 | 0.41 |
| Current ratio | 1.26 | 1.25 | 1.43 | 1.25 | 1.52 | 1.58 | 1.60 | 1.66 | 1.55 | 1.55 |
| Revenue growth | -0.2% | 7.3% | -2.5% | -0.5% | 9.1% | 62.6% | 15.9% | 8.6% | 6.9% | 17.3% |
| EPS growth | — | -214.2% | 30.8% | -5.4% | — | -298.5% | -33.2% | 393.4% | -77.0% | 184.9% |